Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Kumar Jagarlamudi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biomarkers in Medicine|July 25, 2018
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarkerKiran Kumar Jagarlamudi, Martin Shaw
BMC Cancer|April 17, 2015
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarkerKiran Kumar Jagarlamudi, Lars Olof Hansson, Staffan Eriksson
BMC Veterinary Research|October 9, 2014
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarkerKiran Kumar Jagarlamudi, Sara Westberg, Henrik Rönnberg, et al.
BMC Biochemistry|June 30, 2012
Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humansSharif Hanan, Kiran Kumar Jagarlamudi, Wang Liya, et al.
Plos One|September 15, 2015
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease ManagementKiran Kumar Jagarlamudi, Laura Moreau, Sara Westberg, et al.
Frontiers in Veterinary Science|October 9, 2023
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphomaHanan Sharif, Sara Saellström, Bhavya Kolli, et al.
Frontiers in Veterinary Science|May 12, 2025
A novel cross-validated machine learning based Alertix-Cancer Risk Index for early detection of canine malignanciesHanan Sharif, Reza Arabi Belaghi, Kiran Kumar Jagarlamudi, et al.
The Prostate|March 20, 2019
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditionsKiran Kumar Jagarlamudi, Mojca Zupan, Kristina Kumer, et al.
Oncology|September 6, 2023
Clinical Significance of the TK1-Specific Activity in the Early Detection of Ovarian CancerJoško Osredkar, Kiran Kumar Jagarlamudi, Diana Cviič, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biomarkers in Medicine|July 25, 2018
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarkerKiran Kumar Jagarlamudi, Martin Shaw
BMC Cancer|April 17, 2015
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarkerKiran Kumar Jagarlamudi, Lars Olof Hansson, Staffan Eriksson
BMC Veterinary Research|October 9, 2014
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarkerKiran Kumar Jagarlamudi, Sara Westberg, Henrik Rönnberg, et al.
BMC Biochemistry|June 30, 2012
Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humansSharif Hanan, Kiran Kumar Jagarlamudi, Wang Liya, et al.
Plos One|September 15, 2015
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease ManagementKiran Kumar Jagarlamudi, Laura Moreau, Sara Westberg, et al.
Frontiers in Veterinary Science|October 9, 2023
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphomaHanan Sharif, Sara Saellström, Bhavya Kolli, et al.
Frontiers in Veterinary Science|May 12, 2025
A novel cross-validated machine learning based Alertix-Cancer Risk Index for early detection of canine malignanciesHanan Sharif, Reza Arabi Belaghi, Kiran Kumar Jagarlamudi, et al.
The Prostate|March 20, 2019
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditionsKiran Kumar Jagarlamudi, Mojca Zupan, Kristina Kumer, et al.
Oncology|September 6, 2023
Clinical Significance of the TK1-Specific Activity in the Early Detection of Ovarian CancerJoško Osredkar, Kiran Kumar Jagarlamudi, Diana Cviič, et al.
Pageof 1